Navigation Links
Results of the ARCTIC-INTERRUPTION trial presented at TCT 2013
Date:10/31/2013

SAN FRANCISCO, CA October 31, 2013 According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ARCTIC-INTERRUPTION trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

The optimal length of time for DAPT after coronary stenting remains uncertain with an unknown safety to efficacy ratio of prolonged therapy. Currently there are discrepancies between international guidelines and high variability in routine practice. The ARCTIC-INTERRUPTION study was a prospective randomized trial that examined the benefit of the continuation of DAPT for up to two years.

ARCTIC-INTERRUPTION randomly assigned 1,259 patients without major events within the first year after coronary stenting to either a strategy of interruption of DAPT (n=624), or a strategy of continuation for an additional year (n=635). The primary endpoint was the composite of death, myocardial infarction, stent thrombosis, stroke, or urgent revascularization after one year.

The primary endpoint occurred in 3.8 percent of patients in the continuation group, as compared to 4.3 percent in the interruption group. The main secondary endpoint of stent thrombosis or any urgent revascularization occurred in 1.3 percent of patients in the continuation group and 1.6 percent of those in the interruption group. The rate of major bleeding events occurred in 1.1 percent of the patients in the continuation group compared to 0.2 percent in the interruption group.

"The ARCTIC-INTERRUPTION study suggests no ischemic benefit of DAPT continuation beyond one year after stenting in patients that do not experience an adverse event within the first year," said lead investigator Gilles Montalescot, MD, PhD. Dr. Montalescot is Professor of Cardiology at Centre Hospitalier Universitaire Piti-Salptrire in Paris, France.

"Further, the study found significantly more major and minor bleeding events with DAPT continuation."


'/>"/>

Contact: Judy Romero
jromero@crg.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Results of DUTCH PEERS (TWENTE II) trial reported at TCT 2013
2. HIPAA Crackdown Results in Expansion of Secure Texting Solution for Physicians
3. Results of the COREVALVE EXTREME RISK trial presented at TCT 2013
4. Results of the SAFE-PCI trial presented at TCT 2013
5. Aggressive treatment of psoriatic arthritis results in significant improvement, says new research
6. National Resident Matching Program® (NRMP®) Publishes Results of the 2013 Applicant Survey by Preferred Specialty and Applicant Type
7. Visage Sculpture, Premiere Cosmetic Clinic of Boston, Reports Shorter-lasting Results of Fillers in Athletes and Offers a Solution
8. Kimono Condoms are the Thinnest. New Testing Results Confirm
9. IBTA Announces PF23 Results and First-Ever EDR Compliance Testing
10. Diet Doc Hormone Diets & Weight Loss Plans Announces New Medically Guided Diet Plans Designed to Naturally Increase Healthy Hormone Function While Also Producing Results
11. Diet Doc Weight Loss Plans Reveals New Diet Plans and Fat Burning Foods that Help Patients Achieve Snookie Type Weight Loss Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 ... ProBrand Glitch users can easily reveal any logo with a glitch reveal in just a ... control over the style and animation of each preset. Use these presets to add a ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its ... products. Ken was impressed with the safety and reliability of the Stannah Stairlift ... his show. This endorsement by Ken Matthews can be heard on News Radio ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... Smiles by ... Shopping Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled ... services under one roof. Smiles by Seese serves patients of all ages with excellence ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – ... reimbursement questions manufacturers should be asking before selecting an FDA approval pathway? ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 2017 The global preparative and process chromatography ... 2021 from USD 5.49 billion in 2016, at a ... of type, the preparative and process chromatography market is ... the process chromatography segment is expected to account for ... chromatography. Growth in this segment can primarily be attributed ...
(Date:2/16/2017)... , Feb. 16, 2017  Express Scripts (NASDAQ: ... the World,s Most Admired Companies within the Health Care: Pharmacy and ... named one of the World,s Most Admired Companies," said Tim ... by the commitment and passion of our 26,000 employees to make ... serve." ...
(Date:2/16/2017)... and SCOTTSDALE, Ariz. , Feb. ... Health Information Exchange (HIE), announced today it is partnering ... platform. HealthInfoNet,s HIE contains 98% of all Maine ... Maine hospitals and over 500 ambulatory ... of Directors, HealthInfoNet plans to deploy Orion Health,s Amadeus ...
Breaking Medicine Technology: